OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme‐1/cyclooxygenase‐2 inhibitors: Design, synthesis, anti‐hypertensive, anti‐fibrotic, and anti‐inflammatory
Wael A.A. Fadaly, Yaseen A. M. M. Elshaier, Fares E.M. Ali, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 9

Showing 9 citing articles:

Design, Synthesis and Biological Evaluation of Phenoxyacetic Acid derivatives Linked to Pyrazole Scaffold as PPAR-α/γ Agonists and COX-2 Inhibitors with Dual Antidiabetic/Anti-inflammatory Activities
Wael A.A. Fadaly, Dina M.E. Amin, Rania B. Bakr, et al.
Journal of Molecular Structure (2025) Vol. 1340, pp. 142578-142578
Closed Access

Design and synthesis of new pyrazole hybrids linked to oxime and nitrate moieties as COX-2, EGFRL858R/T790M inhibitors and nitric oxide donors with dual anti-inflammatory/anti-proliferative activities
Wael A.A. Fadaly, Mohamed T. M. Nemr, Abeer M. Abd El-Hameed, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108563-108563
Closed Access

Design, synthesis and biological evaluation of thienopyridine derivatives as c-Met kinase inhibitors
Tianyu Xie, Wenbo Hu, Lin You, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3

An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors
Mohamed T. M. Nemr, Mohamad Abdelaziz, Mohamed Teleb, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 2

New chalcone incorporated structurally modified pyridine‐pyrimidine derivatives as anticancer agents: Their design, synthesis, and in‐vitro evaluation
Swarupa Ketha, Chithaluri Sudhakar, Shashikala Kethireddy, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 12
Closed Access

Design, synthesis, and cytotoxicity screening of novel pyrazolopyrimidines over Renal Cell Carcinoma (UO-31 Cells) as p38α inhibitors, and apoptotic cells inducing activities
Mohammed K. Abdelhameid, Amr Sonousi, Aliaa M. Kamal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117005-117005
Closed Access

Page 1

Scroll to top